Dinesh Kadariya, M.B.B.S. (M.D.)

Dinesh Kadariya M.B.B.S. (M.D.)

Assistant Professor

Department: Department of Medicine
Business Phone: (904) 244-5515
Business Email: Dinesh.Kadariya@jax.ufl.edu
Appointments and Locations

Clinical Profile

Specialties
  • Cardiovascular Disease
Interests
  • Clinical Special Interests: Cardiovascular diseases, non-invasive cardiology, multimodality imaging
  • Research Special Interests: Anti-inflammatory therapy in cardiovascular disease, heartfailure, cardiopulmonary exercise

Publications

2024
Acute torrential mitral regurgitation secondary to iatrogenic papillary muscle rupture.
BMJ case reports.17(10):-[DOI] 10.1136/bcr-2024-261836.[PMID] 39477454.
PubMed·Publisher's Site
2024
Cardiovascular Adverse Events Associated With Second-generation Bruton Tyrosine Kinase Inhibitor Therapy: A Systematic Review and Meta-analysis.
Clinical therapeutics.46(2):134-145[DOI] 10.1016/j.clinthera.2023.11.014.[PMID] 38102000.
5 citations·PubMed·Publisher's Site
2024
Delayed Diagnosis of Cardiac Amyloidosis Masked by Chronic Coronary Artery Disease and Ischemic Cardiomyopathy: A Case Report of an Overlooked and Underdiagnosed Etiology.
Cureus.16(6):e63151-[DOI] 10.7759/cureus.63151.[PMID] 39070422.
1 citations·PubMed·Publisher's Site
2024
Differences in clinical presentation and outcomes in pregnancy-associated Takotsubo Syndrome- A scoping review of the literature: Outcomes in pregnancy-associated Takotsubo.
Current problems in cardiology.49(1 Pt C):102175-[DOI] 10.1016/j.cpcardiol.2023.102175.[PMID] 37913927.
PubMed·Publisher's Site
2024
Unveiling sinus venosus atrial septal defect and partial anomalous pulmonary venous return in an elderly patient.
Journal of geriatric cardiology : JGC.21(4):462-464[DOI] 10.26599/1671-5411.2024.04.004.[PMID] 38800542.
PubMed·Publisher's Site
2023
Euglycemic diabetic ketoacidosis caused by empagliflozin complicated by failure to thrive in a geriatric patient.
Archive of clinical cases.10(2):89-92[DOI] 10.22551/2023.39.1002.10248.[PMID] 37313125.
2 citations·PubMed·Publisher's Site
2023
High-Risk Apical Hypertrophic Cardiomyopathy Requiring an Implantable Cardioverter-Defibrillator: A Case Report of an Overlooked Etiology.
Cureus.15(7):e41564-[DOI] 10.7759/cureus.41564.[PMID] 37565123.
1 citations·PubMed·Publisher's Site
2022
Comparison of Cardiorespiratory Fitness in Black or African American Versus Caucasian Patients With Heart Failure.
Journal of cardiopulmonary rehabilitation and prevention.42(1):39-44[DOI] 10.1097/HCR.0000000000000605.[PMID] 34793367.
6 citations·PubMed·Publisher's Site
2022
Early changes in N-terminal pro-brain natriuretic peptide levels predict new-onset heart failure in patients with STEMI.
Minerva cardiology and angiology.70(1):25-31[DOI] 10.23736/S2724-5683.20.05303-7.[PMID] 32657561.
PubMed·Publisher's Site
2022
Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction.
Scientific reports.12(1):1254-[DOI] 10.1038/s41598-022-05374-w.[PMID] 35075216.
21 citations·PubMed·Publisher's Site
2022
Influence of extracellular volume fraction on peak exercise oxygen pulse following thoracic radiotherapy.
Cardio-oncology (London, England).8(1):1-[DOI] 10.1186/s40959-021-00127-6.[PMID] 35042565.
4 citations·PubMed·Publisher's Site
2022
Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials.
European heart journal. Cardiovascular pharmacotherapy.8(5):503-510[DOI] 10.1093/ehjcvp/pvab075.[PMID] 34617567.
54 citations·PubMed·Publisher's Site
2022
Midpoint of energy intake, non-fasting time and cardiorespiratory fitness in heart failure with preserved ejection fraction and obesity.
International journal of cardiology.355():23-27[DOI] 10.1016/j.ijcard.2022.03.010.[PMID] 35276244.
5 citations·PubMed·Publisher's Site
2022
Patient Perceptions of Exertion and Dyspnea With Interleukin-1 Blockade in Patients With Recently Decompensated Systolic Heart Failure.
The American journal of cardiology.174():61-67[DOI] 10.1016/j.amjcard.2022.03.026.[PMID] 35473780.
3 citations·PubMed·Publisher's Site
2022
Safety, Tolerability, and Effects of a Single Subcutaneous Administration of SP16 - a SERPIN-like, Small Peptide Agonist of the Low-Density Lipoprotein-like Receptor 1- on the Acute Inflammatory Response in Patients With ST-Segment Elevation Myocardial Infarction.
Journal of cardiovascular pharmacology.80(5):672-678[DOI] 10.1097/FJC.0000000000001331.[PMID] 35881895.
3 citations·PubMed·Publisher's Site
2022
Sarcopenic Obesity Is Associated With Reduced Cardiorespiratory Fitness Compared With Nonsarcopenic Obesity in Patients With Heart Failure With Reduced Ejection Fraction.
Circulation. Heart failure.15(10):e009518-[DOI] 10.1161/CIRCHEARTFAILURE.122.009518.[PMID] 36098058.
22 citations·PubMed·Publisher's Site
2021
A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers.
PloS one.16(5):e0247357-[DOI] 10.1371/journal.pone.0247357.[PMID] 33956804.
8 citations·PubMed·Publisher's Site
2021
Clinical features and outcomes between African American and Caucasian patients with Takotsubo Syndrome.
Minerva cardiology and angiology.69(6):750-759[DOI] 10.23736/S2724-5683.20.05456-0.[PMID] 33427424.
6 citations·PubMed·Publisher's Site
2021
Edema Index Predicts Cardiorespiratory Fitness in Patients With Heart Failure With Reduced Ejection Fraction and Type 2 Diabetes Mellitus.
Journal of the American Heart Association.10(8):e018631-[DOI] 10.1161/JAHA.120.018631.[PMID] 33825487.
4 citations·PubMed·Publisher's Site
2021
Effect of Canagliflozin Compared With Sitagliptin on Serum Lipids in Patients with Type 2 Diabetes Mellitus and Heart Failure with Reduced Ejection Fraction: A Post-Hoc Analysis of the CANA-HF Study.
Journal of cardiovascular pharmacology.78(3):407-410[DOI] 10.1097/FJC.0000000000001083.[PMID] 34132690.
PubMed·Publisher's Site
2021
Orthostatic intolerance syndromes after hematopoietic cell transplantation: clinical characteristics and therapeutic interventions in a single-center experience.
Cardio-oncology (London, England).7(1):40-[DOI] 10.1186/s40959-021-00126-7.[PMID] 34847948.
4 citations·PubMed·Publisher's Site
2021
The Chronic Kidney Disease Phenotype of HFpEF: Unique Cardiac Characteristics.
The American journal of cardiology.142():143-145[DOI] 10.1016/j.amjcard.2020.12.012.[PMID] 33333073.
7 citations·PubMed·Publisher's Site
2021
Time of eating and cardiorespiratory fitness in patients with heart failure with preserved ejection fraction and obesity.
Nutrition, metabolism, and cardiovascular diseases : NMCD.31(8):2471-2473[DOI] 10.1016/j.numecd.2021.04.018.[PMID] 34112580.
6 citations·PubMed·Publisher's Site
2020
Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute Pericarditis.
Journal of cardiovascular pharmacology.76(1):50-52[DOI] 10.1097/FJC.0000000000000847.[PMID] 32398478.
26 citations·PubMed·Publisher's Site
2020
Determinants of Cardiorespiratory Fitness Following Thoracic Radiotherapy in Lung or Breast Cancer Survivors.
The American journal of cardiology.125(6):988-996[DOI] 10.1016/j.amjcard.2019.12.019.[PMID] 31928717.
16 citations·PubMed·Publisher's Site
2020
Determinants of Cardiorespiratory Fitness in Patients with Heart Failure Across a Wide Range of Ejection Fractions.
The American journal of cardiology.125(1):76-81[DOI] 10.1016/j.amjcard.2019.09.036.[PMID] 31703805.
10 citations·PubMed·Publisher's Site
2020
Interleukin-1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST-Segment-Elevation Myocardial Infarction.
Journal of the American Heart Association.9(5):e014941-[DOI] 10.1161/JAHA.119.014941.[PMID] 32122219.
196 citations·PubMed·Publisher's Site
2020
Peak Oxygen Uptake Recovery Delay After Maximal Exercise in Patients With Heart Failure.
Journal of cardiopulmonary rehabilitation and prevention.40(6):434-437[DOI] 10.1097/HCR.0000000000000502.[PMID] 32332250.
2 citations·PubMed·Publisher's Site
2020
Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart Failure.
Journal of cardiovascular pharmacology.77(1):49-60[DOI] 10.1097/FJC.0000000000000931.[PMID] 33235030.
85 citations·PubMed·Publisher's Site
2020
The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA-HF study.
Diabetes/metabolism research and reviews.36(8):e3335-[DOI] 10.1002/dmrr.3335.[PMID] 32415802.
41 citations·PubMed·Publisher's Site
2019
Alirocumab in Acute Myocardial Infarction: Results From the Virginia Commonwealth University Alirocumab Response Trial (VCU-AlirocRT).
Journal of cardiovascular pharmacology.74(3):266-269[DOI] 10.1097/FJC.0000000000000706.[PMID] 31356537.
29 citations·PubMed·Publisher's Site
2019
Association of Anti-Mullerian Hormone with C-Reactive Protein in Men.
Scientific reports.9(1):13081-[DOI] 10.1038/s41598-019-49596-x.[PMID] 31511566.
6 citations·PubMed·Publisher's Site
2019
IL-1 Blockade Reduces Inflammation in Pulmonary Arterial Hypertension and Right Ventricular Failure: A Single-Arm, Open-Label, Phase IB/II Pilot Study.
American journal of respiratory and critical care medicine.199(3):381-384[DOI] 10.1164/rccm.201809-1631LE.[PMID] 30418047.
71 citations·PubMed·Publisher's Site
2019
Noninvasive Hemodynamic Monitoring of Cocaine-Induced Changes in Cardiac Output and Systemic Vascular Resistance in Subjects With Chronic Cocaine Use Disorder.
Journal of cardiovascular pharmacology.74(6):528-534[DOI] 10.1097/FJC.0000000000000740.[PMID] 31809403.
1 citations·PubMed·Publisher's Site
2019
Potential role for interleukin-1 in the cardio-renal syndrome.
European journal of heart failure.21(3):385-386[DOI] 10.1002/ejhf.1403.[PMID] 30666820.
8 citations·PubMed·Publisher's Site
2019
Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance.
The American journal of cardiology.123(3):466-473[DOI] 10.1016/j.amjcard.2018.10.027.[PMID] 30502049.
40 citations·PubMed·Publisher's Site
2019
Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity and HFpEF: The UFA-Preserved Pilot Study.
JACC. Basic to translational science.4(4):563-565[DOI] 10.1016/j.jacbts.2019.04.001.[PMID] 31468011.
29 citations·PubMed·Publisher's Site
2018
C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction.
Frontiers in cardiovascular medicine.5():178-[DOI] 10.3389/fcvm.2018.00178.[PMID] 30619885.
20 citations·PubMed·Publisher's Site
2018
Effect of Interleukin-1 Blockade on Left Ventricular Systolic Performance and Work: A Post Hoc Pooled Analysis of 2 Clinical Trials.
Journal of cardiovascular pharmacology.72(1):68-70[DOI] 10.1097/FJC.0000000000000591.[PMID] 29738374.
19 citations·PubMed·Publisher's Site
2018
Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics.
Diabetes, obesity & metabolism.20(8):2014-2018[DOI] 10.1111/dom.13309.[PMID] 29603546.
27 citations·PubMed·Publisher's Site
2018
IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.
Circulation. Heart failure.11(8):e005036-[DOI] 10.1161/CIRCHEARTFAILURE.118.005036.[PMID] 30354558.
145 citations·PubMed·Publisher's Site
2018
Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction.
ESC heart failure.5(2):372-378[DOI] 10.1002/ehf2.12235.[PMID] 29345112.
46 citations·PubMed·Publisher's Site
2018
Rationale and design of the Virginia Commonwealth University-Anakinra Remodeling Trial-3 (VCU-ART3): A randomized, placebo-controlled, double-blinded, multicenter study.
Clinical cardiology.41(8):1004-1008[DOI] 10.1002/clc.22988.[PMID] 30033595.
43 citations·PubMed·Publisher's Site
2018
Usefulness of Canakinumab to Improve Exercise Capacity in Patients With Long-Term Systolic Heart Failure and Elevated C-Reactive Protein.
The American journal of cardiology.122(8):1366-1370[DOI] 10.1016/j.amjcard.2018.07.002.[PMID] 30244844.
57 citations·PubMed·Publisher's Site
2017
Clinical utility of evolocumab in the management of hyperlipidemia: patient selection and follow-up.
Drug design, development and therapy.11():2121-2129[DOI] 10.2147/DDDT.S114091.[PMID] 28744103.
8 citations·PubMed·Publisher's Site
2017
Dietary Fat, Sugar Consumption, and Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction.
JACC. Basic to translational science.2(5):513-525[DOI] 10.1016/j.jacbts.2017.06.009.[PMID] 30062167.
54 citations·PubMed·Publisher's Site
2017
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial).
Circulation. Heart failure.10(11):-[DOI] 10.1161/CIRCHEARTFAILURE.117.004373.[PMID] 29141858.
184 citations·PubMed·Publisher's Site
2017
Severely Impaired Cardiorespiratory Fitness in Patients With Recently Decompensated Systolic Heart Failure.
The American journal of cardiology.120(10):1854-1857[DOI] 10.1016/j.amjcard.2017.07.099.[PMID] 28867128.
10 citations·PubMed·Publisher's Site

Office Information

Academic Office
5th Floor, Ambulatory Care Center
655 West 8th Street, C35
Jacksonville, FL 32209
(904) 244-5515
 Dinesh.Kadariya@jax.ufl.edu
Administrative Assistant
 Jurnee Stepps
(904) 244-5515
jurnee.stepps@jax.ufl.edu

Education

Medical Degree
2006 · -Nalanda Medical College & Hospital, Patna, India
Internal Medicine Residency
2013 · Albert Einstein College of Medicine, Bronx, NY, USA
Cardiovascular Disease Fellowship
2022 · Virginia Commonwealth University Health System, Richmond, VA, USA